Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

Clinical trial NCT06976021 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06976021
Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Uterine Cervical Cancer Uterine Corpus Cancer Malignant Melanoma Clear Cell Renal Cell Carcinoma

Start date: 2025-06-01
Primary completion: 2029-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.